Literature DB >> 19190527

Molecular pathogenesis of Staphylococcus aureus infection.

George Y Liu1.   

Abstract

S. aureus has evolved a comprehensive strategy to address the challenges posed by the human immune system. The emergence of community-associated methicillin-resistant S. aureus (CA-MRSA) infections in individuals with no predisposing conditions suggests an increased pathogenicity of the bacterium, which may be related to acquisition of novel genetic elements. Remarkably, despite an abundance of research, the underlying cause of the epidemic is not known. Here, the various strategies used by S. aureus to evade obstacles laid out by the human host during colonization and infection were reviewed. The controversies surrounding MRSA research were described, and how acquisition of the novel genes could explain the increased incidence and severity of CA-MRSA diseases was described.

Entities:  

Mesh:

Year:  2009        PMID: 19190527      PMCID: PMC2919328          DOI: 10.1203/PDR.0b013e31819dc44d

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  80 in total

1.  Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.

Authors:  Binh An Diep; Henry F Chambers; Christopher J Graber; John D Szumowski; Loren G Miller; Linda L Han; Jason H Chen; Felice Lin; Jessica Lin; Tiffany HaiVan Phan; Heather A Carleton; Linda K McDougal; Fred C Tenover; Daniel E Cohen; Kenneth H Mayer; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  Ann Intern Med       Date:  2008-01-30       Impact factor: 25.391

2.  A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence.

Authors:  Chia-I Liu; George Y Liu; Yongcheng Song; Fenglin Yin; Mary E Hensler; Wen-Yih Jeng; Victor Nizet; Andrew H-J Wang; Eric Oldfield
Journal:  Science       Date:  2008-02-14       Impact factor: 47.728

3.  Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004.

Authors:  Rachel J Gorwitz; Deanna Kruszon-Moran; Sigrid K McAllister; Geraldine McQuillan; Linda K McDougal; Gregory E Fosheim; Bette J Jensen; George Killgore; Fred C Tenover; Matthew J Kuehnert
Journal:  J Infect Dis       Date:  2008-05-01       Impact factor: 5.226

4.  A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005.

Authors:  Catherine Liu; Christopher J Graber; Michael Karr; Binh An Diep; Li Basuino; Brian S Schwartz; Mark C Enright; Simon J O'Hanlon; Jonathon C Thomas; Francoise Perdreau-Remington; Shelley Gordon; Helen Gunthorpe; Richard Jacobs; Peter Jensen; Gifford Leoung; James S Rumack; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

5.  Pneumococcal conjugate vaccine does not influence Staphylococcus aureus carriage in young children with acute otitis media.

Authors:  Robert Cohen; Corinne Levy; Franck Thollot; France de La Rocque; Marc Koskas; Eric Bonnet; Bernard Fritzell; Emmanuelle Varon
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

Review 6.  Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Loren G Miller; Binh An Diep
Journal:  Clin Infect Dis       Date:  2008-03-01       Impact factor: 9.079

7.  Role of Staphylococcus aureus catalase in niche competition against Streptococcus pneumoniae.

Authors:  Bonggoo Park; Victor Nizet; George Y Liu
Journal:  J Bacteriol       Date:  2008-01-25       Impact factor: 3.490

8.  Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans.

Authors:  Heiman F L Wertheim; Evelyn Walsh; Roos Choudhurry; Damian C Melles; Hélène A M Boelens; Helen Miajlovic; Henri A Verbrugh; Timothy Foster; Alex van Belkum
Journal:  PLoS Med       Date:  2008-01-15       Impact factor: 11.069

9.  Vaccine protection against Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Olaf Schneewind
Journal:  J Exp Med       Date:  2008-02-11       Impact factor: 14.307

10.  A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages.

Authors:  Malgorzata Kubica; Krzysztof Guzik; Joanna Koziel; Miroslaw Zarebski; Walter Richter; Barbara Gajkowska; Anna Golda; Agnieszka Maciag-Gudowska; Klaudia Brix; Les Shaw; Timothy Foster; Jan Potempa
Journal:  PLoS One       Date:  2008-01-09       Impact factor: 3.240

View more
  58 in total

1.  Probiotic fengycins dis(Agr)ee with Staphylococcus aureus colonization.

Authors:  Lawton K Chung; Manuela Raffatellu
Journal:  Cell Res       Date:  2019-02       Impact factor: 25.617

2.  Comparison of antibiotic resistance, virulence gene profiles, and pathogenicity of methicillin-resistant and methicillin-susceptible Staphylococcus aureus using a Caenorhabditis elegans infection model.

Authors:  Terissa Thompson; Paul D Brown
Journal:  Pathog Glob Health       Date:  2014-10-16       Impact factor: 2.894

3.  Analysis of the effects of cigarette smoke on staphylococcal virulence phenotypes.

Authors:  Elisa K McEachern; John H Hwang; Katherine M Sladewski; Shari Nicatia; Carola Dewitz; Denzil P Mathew; Victor Nizet; Laura E Crotty Alexander
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

4.  Immunomodulatory effects of recombinant lactoferrin during MRSA infection.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Int Immunopharmacol       Date:  2014-03-06       Impact factor: 4.932

Review 5.  Metabolic control of virulence factor production in Staphylococcus aureus.

Authors:  Paulami Rudra; Jeffrey M Boyd
Journal:  Curr Opin Microbiol       Date:  2020-05-07       Impact factor: 7.934

Review 6.  Microbial functional amyloids serve diverse purposes for structure, adhesion and defence.

Authors:  Nirukshan Shanmugam; Max O D G Baker; Sarah R Ball; Megan Steain; Chi L L Pham; Margaret Sunde
Journal:  Biophys Rev       Date:  2019-05-02

7.  Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines.

Authors:  Pinky Mal; Kallol Dutta; Debasish Bandyopadhyay; Anirban Basu; Rajni Khan; Biswadev Bishayi
Journal:  Inflamm Res       Date:  2012-11-15       Impact factor: 4.575

Review 8.  Chromogenic media for MRSA diagnostics.

Authors:  Zhenbo Xu; Yuchao Hou; Brian M Peters; Dingqiang Chen; Bing Li; Lin Li; Mark E Shirtliff
Journal:  Mol Biol Rep       Date:  2016-08-25       Impact factor: 2.316

Review 9.  Microbial amyloids--functions and interactions within the host.

Authors:  Kelly Schwartz; Blaise R Boles
Journal:  Curr Opin Microbiol       Date:  2013-01-09       Impact factor: 7.934

10.  Increased in vitro phenol-soluble modulin production is associated with soft tissue infection source in clinical isolates of methicillin-susceptible Staphylococcus aureus.

Authors:  Robert Qi; Hwang-Soo Joo; Batu Sharma-Kuinkel; Nicholas R Berlon; Lawrence Park; Chih-Lung Fu; Julia A Messina; Joshua T Thaden; Qin Yan; Felicia Ruffin; Stacey Maskarinec; Bobby Warren; Vivian H Chu; Claudio Q Fortes; Efthymia Giannitsioti; Emanuele Durante-Mangoni; Zeina A Kanafani; Michael Otto; Vance G Fowler
Journal:  J Infect       Date:  2016-01-09       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.